Arieh Bergman, MD
Obstetrics/Gynecology · Beveerly Hills
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 53 years
- Graduated 1973
Offices
1 location
Looking this up.
Hospitals listed: Adventist Health Simi Valley · Henry Mayo Newhall Hospital · Northridge Hospital Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bergman’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A41085 · Current
Licensed to practise in California · since 1984 · expires 2028-08-31 · Tel Aviv University, Sackler School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Simi ValleySimi Valley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 3.418, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.159, Oct 2024 – Sep 2025
- Henry Mayo Newhall HospitalValencia, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency department · Birthing-friendlyPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Pressure ulcer rate: 1.42 (0.65 to 2.18) · 4,172 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.206, Oct 2024 – Sep 2025
- Northridge Hospital Medical CenterNorthridge, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.11, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.147, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.173, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Simi Valley
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 3.418 | Worse | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.159 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 722 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.69 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 195.92 (137.46 to 254.38) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 128 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.4 · 128 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 469 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 164 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 1,835 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,577 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 4,587 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.34 to 6.95) · 698 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.1 (0.39 to 3.82) · 147 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.04 to 4.31) · 675 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.9 (3.52 to 22.28) · 145 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.67 (2.48 to 10.87) · 139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 162 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 3,793 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 2.753 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 146 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.5 · 450 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.5 · 131 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 28.8 · 349 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 29.1 · 490 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.4 · 531 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 75 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.5 to 18.7) · 353 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 157 cases | No different | Jan 2024 – Dec 2024 |
What patients said (486 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 82% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Henry Mayo Newhall Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 3 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 1.42 (0.65 to 2.18) · 4,172 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.206 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.37 (0.37 to 2.37) · 885 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.22 (0.84 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 172.82 (119.12 to 226.52) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.7 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.6 · 128 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 285 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 410 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 214 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 2,687 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,440 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 4,489 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.34 (1.07 to 5.61) · 837 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 193 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.64 to 3.81) · 798 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.74 (0.67 to 18.81) · 197 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.72 (0.6 to 8.85) · 177 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.99 (0.5 to 3.48) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.2 · 66 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.405 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 2.021 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.067 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.091 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 254 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 586 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 52.4 · 118 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 21.4 · 333 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 628 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 31 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 225 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.3 (10.8 to 19.1) · 246 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 302 cases | No different | Jan 2024 – Dec 2024 |
What patients said (607 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Northridge Hospital Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.11 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.147 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.13 to 2.13) · 1,012 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.78 (0.44 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.43 (96.43 to 190.42) · 88 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 216 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 457 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.4 · 384 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 315 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,091 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.44) · 6,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 6,139 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,225 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.24) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.28 to 3.34) · 1,193 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.26 (0 to 15.07) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.14 (2.11 to 10.16) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.14) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.76) · 5,578 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 139 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 1.041 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 368 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 674 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 27.2 · 214 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.2 · 563 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 23.8 · 438 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 484 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.1 to 7.4) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.9 (6.8 to 13.8) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 166 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.9 · 57 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 141 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 165 cases | No different | Jan 2024 – Dec 2024 |
What patients said (621 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$272,670
Medicare paid this office $272,670 for 363 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dilation of bladder using an endoscope | 308 | $99,071 | $317 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 242 | $82,404 | $330 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 142 | $45,893 | $319 |
| Complex measurement of pressure of urine flow in bladder | 69 | $18,581 | $269 |
| Study of rectum sensitivity and function | 47 | $11,410 | $243 |
See all 9 services
| Dilation of bladder using an endoscope | 308 | $99,071 | $317 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 242 | $82,404 | $330 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 142 | $45,893 | $319 |
| Complex measurement of pressure of urine flow in bladder | 69 | $18,581 | $269 |
| Study of rectum sensitivity and function | 47 | $11,410 | $243 |
| Assessment of muscle signal of pelvic nerves | 23 | $5,581 | $243 |
| New patient visit (45+ min) | 32 | $3,985 | $125 |
| Exam of cervix and upper part of vagina using an endoscope | 15 | $1,650 | $110 |
| Complete ultrasound scan of pelvis | 13 | $1,517 | $95 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Dilation of bladder using an endoscope | 409 | 288 | 322 | 332 | 314 | 313 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 336 | 185 | 218 | 237 | 250 | 250 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 226 | 125 | 156 | 158 | 151 | 144 |
| Complex measurement of pressure of urine flow in bladder | 146 | 81 | 91 | 85 | 75 | 69 |
| Assessment of muscle signal of pelvic nerves | 55 | 35 | 54 | 24 | 32 | 23 |
| Complicated insertion of bladder tube | 44 | 11 | 25 | 16 | 14 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
363 Original Medicare patients in 2024. Average age 76 · Women 100% · Also on Medicaid 9% · Health risk score 0.99. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 69% · Diabetes 27% · Coronary heart disease 26% · Depression 25% · Cancer 15% · Atrial fibrillation 13% · Chronic kidney disease 12% · COPD 11% · Heart failure 10% · Stroke 8% · Dementia 4%.
The office billed $483,810, Medicare allowed $355,497 and paid $272,670; for 933 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 363 | 933 | 76 | 0.99 | $483,810 | $272,670 |
| 2023 | 355 | 938 | 75 | 0.91 | $500,740 | $279,751 |
| 2022 | 375 | 1,008 | 75 | 0.92 | $550,415 | $296,445 |
| 2021 | 392 | 1,146 | 75 | 0.93 | $541,145 | $320,850 |
| 2020 | 396 | 1,014 | 75 | 1.06 | $454,960 | $255,006 |
| 2019 | 475 | 1,401 | 75 | 1.08 | $683,190 | $371,662 |
| 2018 | 526 | 1,593 | 76 | 1.10 | $783,175 | $399,471 |
| 2017 | 523 | 1,568 | 76 | 1.14 | $766,475 | $375,483 |
| 2016 | 551 | 1,735 | 76 | 1.11 | $843,155 | $429,237 |
| 2015 | 575 | 1,848 | 76 | 1.08 | $889,655 | $464,641 |
| 2014 | 577 | 1,872 | 76 | 1.07 | $895,925 | $474,127 |
| 2013 | 591 | 1,938 | 76 | 1.09 | $924,165 | $496,151 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Dilation of bladder using an endoscope | 309 | $103,113 | $328 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 246 | $81,284 | $325 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 149 | $48,539 | $321 |
| Complex measurement of pressure of urine flow in bladder | 74 | $19,832 | $264 |
| Study of rectum sensitivity and function | 49 | $11,630 | $237 |
| Assessment of muscle signal of pelvic nerves | 32 | $7,682 | $240 |
| New patient visit (45+ min) | 13 | $1,810 | $139 |
| Complicated insertion of bladder tube | 13 | $1,734 | $124 |
| Exam of cervix and upper part of vagina using an endoscope | 13 | $1,451 | $112 |
| Complete ultrasound scan of pelvis | 11 | $1,163 | $89 |
2022: 11 services
| Dilation of bladder using an endoscope | 331 | $109,410 | $330 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 237 | $80,934 | $341 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 156 | $51,973 | $329 |
| Complex measurement of pressure of urine flow in bladder | 85 | $23,067 | $271 |
| Study of rectum sensitivity and function | 50 | $12,759 | $250 |
| Assessment of muscle signal of pelvic nerves | 24 | $5,891 | $245 |
| Complete ultrasound scan of pelvis | 45 | $4,292 | $95 |
| Complicated insertion of bladder tube | 16 | $2,209 | $138 |
| New patient visit (45+ min) | 19 | $2,070 | $109 |
| Short return visit (20+ min) | 16 | $1,594 | $76 |
| Exam of cervix and upper part of vagina using an endoscope | 14 | $1,514 | $108 |
2021: 11 services
| Dilation of bladder using an endoscope | 321 | $111,802 | $347 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 216 | $76,485 | $351 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 156 | $49,996 | $320 |
| Complex measurement of pressure of urine flow in bladder | 91 | $25,096 | $276 |
| Study of rectum sensitivity and function | 77 | $19,155 | $246 |
| Assessment of muscle signal of pelvic nerves | 54 | $13,262 | $246 |
| Complete ultrasound scan of pelvis | 109 | $10,867 | $99 |
| New patient visit (45+ min) | 31 | $4,330 | $140 |
| Complicated insertion of bladder tube | 25 | $3,404 | $136 |
| Short return visit (20+ min) | 16 | $2,033 | $75 |
| Exam of cervix and upper part of vagina using an endoscope | 16 | $1,461 | $91 |
2020: 11 services
| Dilation of bladder using an endoscope | 287 | $97,074 | $337 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 185 | $58,887 | $318 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 123 | $37,806 | $302 |
| Complex measurement of pressure of urine flow in bladder | 81 | $20,095 | $248 |
| Study of rectum sensitivity and function | 51 | $11,056 | $213 |
| Short return visit (20+ min) | 122 | $8,135 | $64 |
| Assessment of muscle signal of pelvic nerves | 35 | $7,461 | $213 |
| Complete ultrasound scan of pelvis | 63 | $6,409 | $102 |
| Diagnostic exam of bladder and urethra using an endoscope | 12 | $2,195 | $183 |
| New patient visit (45+ min) | 15 | $2,104 | $140 |
| Complicated insertion of bladder tube | 11 | $1,390 | $126 |
2019: 10 services
| Dilation of bladder using an endoscope | 409 | $128,907 | $315 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 333 | $102,209 | $304 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 225 | $64,086 | $284 |
| Complex measurement of pressure of urine flow in bladder | 145 | $34,330 | $235 |
| Study of rectum sensitivity and function | 80 | $16,448 | $206 |
| Assessment of muscle signal of pelvic nerves | 55 | $10,574 | $192 |
| Complicated insertion of bladder tube | 44 | $4,988 | $113 |
| Complete ultrasound scan of pelvis | 22 | $2,484 | $92 |
| Exam of cervix and upper part of vagina using an endoscope | 26 | $2,377 | $91 |
| Short return visit (20+ min) | 12 | $998 | $62 |
2018: 9 services
| Dilation of bladder using an endoscope | 427 | $129,858 | $303 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 367 | $103,818 | $281 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 287 | $75,673 | $263 |
| Complex measurement of pressure of urine flow in bladder | 185 | $41,036 | $221 |
| Study of rectum sensitivity and function | 122 | $23,091 | $186 |
| Assessment of muscle signal of pelvic nerves | 81 | $14,091 | $174 |
| Complicated insertion of bladder tube | 38 | $4,240 | $106 |
| Exam of cervix and upper part of vagina using an endoscope | 35 | $2,797 | $78 |
| Complete ultrasound scan of pelvis | 14 | $1,332 | $89 |
2017: 11 services
| Dilation of bladder using an endoscope | 423 | $122,679 | $289 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 364 | $100,824 | $275 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 286 | $72,180 | $251 |
| Complex measurement of pressure of urine flow in bladder | 169 | $36,082 | $214 |
| Study of rectum sensitivity and function | 97 | $17,590 | $179 |
| Assessment of muscle signal of pelvic nerves | 76 | $12,673 | $165 |
| Complicated insertion of bladder tube | 47 | $4,484 | $93 |
| Exam of cervix and upper part of vagina using an endoscope | 34 | $2,885 | $85 |
| Complete ultrasound scan of pelvis | 28 | $2,712 | $87 |
| Diagnostic exam of bladder and urethra using an endoscope | 11 | $1,369 | $124 |
| Biopsy of lining of uterus | 13 | $1,147 | $88 |
2016: 11 services
| Dilation of bladder using an endoscope | 429 | $129,610 | $301 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 386 | $108,684 | $279 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 290 | $76,349 | $260 |
| Complex measurement of pressure of urine flow in bladder | 212 | $47,900 | $222 |
| Study of rectum sensitivity and function | 145 | $27,517 | $187 |
| Assessment of muscle signal of pelvic nerves | 71 | $12,861 | $181 |
| Needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 48 | $10,311 | $215 |
| Complicated insertion of bladder tube | 33 | $3,600 | $103 |
| Exam of cervix and upper part of vagina using an endoscope | 34 | $3,176 | $91 |
| Complete ultrasound scan of pelvis | 19 | $1,972 | $94 |
| Biopsy of lining of uterus | 16 | $1,385 | $87 |
2015: 12 services
| Dilation of bladder using an endoscope | 448 | $138,417 | $309 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 367 | $106,666 | $287 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 338 | $90,988 | $268 |
| Complex measurement of pressure of urine flow in bladder | 230 | $51,536 | $223 |
| Needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 137 | $30,170 | $215 |
| Study of rectum sensitivity and function | 99 | $19,061 | $193 |
| Assessment of muscle signal of pelvic nerves | 53 | $9,527 | $176 |
| Complicated insertion of bladder tube | 37 | $3,847 | $104 |
| Complete ultrasound scan of pelvis | 37 | $3,285 | $86 |
| Diagnostic exam of bladder and urethra using an endoscope | 19 | $3,226 | $170 |
| Exam of cervix and upper part of vagina using an endoscope | 20 | $1,922 | $92 |
| Biopsy of lining of uterus | 13 | $1,108 | $85 |
2014: 11 services
| Dilation of bladder using an endoscope | 443 | $137,458 | $310 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 389 | $114,810 | $291 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 332 | $88,531 | $267 |
| Complex measurement of pressure of urine flow in bladder | 231 | $51,423 | $222 |
| Needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 141 | $31,638 | $220 |
| Study of rectum sensitivity and function | 118 | $22,888 | $189 |
| Assessment of muscle signal of pelvic nerves | 72 | $13,014 | $181 |
| Complicated insertion of bladder tube | 36 | $3,859 | $107 |
| Exam of cervix and upper part of vagina using an endoscope | 26 | $2,110 | $81 |
| Complete ultrasound scan of pelvis | 19 | $1,954 | $98 |
| Injection of anesthetic agent and/or steroid into external genitals and anus nerve | 11 | $1,327 | $121 |
2013: 12 services
| Dilation of bladder using an endoscope | 445 | $139,007 | $312 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 407 | $120,526 | $295 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 355 | $97,696 | $274 |
| Complex measurement of pressure of urine flow in bladder | 253 | $56,576 | $224 |
| Needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 132 | $30,084 | $225 |
| Study of rectum sensitivity and function | 108 | $21,141 | $196 |
| Assessment of muscle signal of pelvic nerves | 72 | $13,203 | $183 |
| Complicated insertion of bladder tube | 38 | $4,274 | $107 |
| Complete ultrasound scan of pelvis | 22 | $2,699 | $112 |
| Injection of anesthetic agent and/or steroid into external genitals and anus nerve | 21 | $2,650 | $120 |
| Injection of anesthetic agent, paracervical (uterine) nerve | 17 | $2,135 | $119 |
| Exam of cervix and upper part of vagina using an endoscope | 16 | $1,577 | $93 |
Drugs they prescribed that Part D paid
$70,231
Pharmacies billed $70,231 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 667) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
567 generic and fewer than 11 brand-name prescriptions · $70,231 in drug cost · 216 antibiotic prescriptions to 99 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 32 | $29,514 | $922 |
| Premarin | 21 | $8,734 | $416 |
| Estradiol | 96 | $6,430 | $67 |
| Imvexxy | 20 | $5,475 | $274 |
| Yuvafem | 18 | $2,895 | $161 |
See all 17 drugs
| Myrbetriq | 32 | $29,514 | $922 |
| Premarin | 21 | $8,734 | $416 |
| Estradiol | 96 | $6,430 | $67 |
| Imvexxy | 20 | $5,475 | $274 |
| Yuvafem | 18 | $2,895 | $161 |
| Nitrofurantoin Mono-Macro | 90 | $1,593 | $18 |
| Oxybutynin Chloride Er | 53 | $1,516 | $29 |
| Mometasone Furoate | 64 | $949 | $15 |
| Fesoterodine Fumarate Er | 12 | $493 | $41 |
| Progesterone | 11 | $437 | $40 |
| Amoxicillin-Clavulanate Potass | 14 | $211 | $15 |
| Cephalexin | 23 | $179 | $8 |
| Cefuroxime | 12 | $134 | $11 |
| Levofloxacin | 19 | $65 | $3 |
| Ciprofloxacin | 15 | $54 | $4 |
| Fluconazole | 16 | $44 | $3 |
| Sulfamethoxazole-Trimethoprim | 18 | $32 | $2 |
Year by year
| 2024 | 667 | 188 | 0% (0) | None | $70,231 |
| 2023 | 723 | 181 | 0% (0) | None | $104,495 |
| 2022 | 854 | 227 | 0% (0) | None | $126,411 |
| 2021 | 926 | 244 | 0% (0) | 25% | $130,981 |
| 2020 | 986 | 258 | 0% (0) | 31% | $169,899 |
| 2019 | 1,110 | 287 | 0% (0) | None | $216,358 |
| 2018 | 1,130 | 262 | 0% (0) | 34% | $206,229 |
| 2017 | 976 | 260 | 0% (0) | 31% | $183,941 |
| 2016 | 1,087 | 281 | None | None | $186,767 |
| 2015 | 1,166 | 273 | 0% (0) | None | $159,645 |
| 2014 | 1,282 | 269 | None | None | $137,723 |
| 2013 | 1,348 | 284 | None | None | $130,183 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Myrbetriq | 49 | $48,584 | $992 |
| Premarin | 18 | $8,675 | $482 |
| Estradiol | 105 | $8,675 | $83 |
| Imvexxy | 19 | $5,358 | $282 |
| Nitrofurantoin Mono-Macro | 90 | $3,041 | $34 |
| Yuvafem | 13 | $2,194 | $169 |
| Mometasone Furoate | 76 | $1,613 | $21 |
| Solifenacin | 12 | $1,336 | $111 |
| Oxybutynin Chloride Er | 22 | $1,043 | $47 |
| Sulfamethoxazole-Trimethoprim | 20 | $394 | $20 |
| Cephalexin | 21 | $277 | $13 |
| Levofloxacin | 20 | $274 | $14 |
| Ciprofloxacin | 27 | $270 | $10 |
| Amoxicillin-Clavulanate Potass | 13 | $150 | $12 |
| Fluconazole | 26 | $113 | $4 |
2022: 20 drugs
| Myrbetriq | 54 | $46,857 | $868 |
| Premarin | 30 | $12,218 | $407 |
| Estradiol | 101 | $10,283 | $102 |
| Nitrofurantoin Mono-Macro | 121 | $3,941 | $33 |
| Tolterodine Tartrate Er | 16 | $3,181 | $199 |
| Yuvafem | 17 | $3,115 | $183 |
| Solifenacin | 15 | $2,200 | $147 |
| Oxybutynin Chloride Er | 30 | $1,733 | $58 |
| Mometasone Furoate | 71 | $1,355 | $19 |
| Clobetasol Propionate | 14 | $1,289 | $92 |
| Progesterone | 13 | $1,035 | $80 |
| Valacyclovir | 14 | $788 | $56 |
| Sulfamethoxazole-Trimethoprim | 21 | $346 | $16 |
| Cephalexin | 28 | $192 | $7 |
| Levofloxacin | 25 | $183 | $7 |
| Fluconazole | 29 | $168 | $6 |
| Cefuroxime | 12 | $163 | $14 |
| Tamsulosin | 12 | $149 | $12 |
| Ciprofloxacin | 27 | $129 | $5 |
| Amoxicillin-Clavulanate Potass | 20 | $121 | $6 |
2021: 20 drugs
| Myrbetriq | 48 | $33,205 | $692 |
| Premarin | 39 | $15,208 | $390 |
| Toviaz | 23 | $14,859 | $646 |
| Estradiol | 116 | $14,371 | $124 |
| Yuvafem | 32 | $5,590 | $175 |
| Nitrofurantoin Mono-Macro | 117 | $4,284 | $37 |
| Tolterodine Tartrate Er | 12 | $2,840 | $237 |
| Valacyclovir | 24 | $1,839 | $77 |
| Oxybutynin Chloride Er | 28 | $1,676 | $60 |
| Mometasone Furoate | 83 | $1,523 | $18 |
| Progesterone | 19 | $1,309 | $69 |
| Solifenacin | 26 | $1,174 | $45 |
| Clobetasol Propionate | 13 | $414 | $32 |
| Imipramine | 13 | $235 | $18 |
| Amoxicillin-Clavulanate Potass | 21 | $218 | $10 |
| Sulfamethoxazole-Trimethoprim | 21 | $196 | $9 |
| Ciprofloxacin | 39 | $136 | $3 |
| Levofloxacin | 19 | $134 | $7 |
| Cephalexin | 15 | $124 | $8 |
| Fluconazole | 29 | $101 | $3 |
2020: 22 drugs
| Myrbetriq | 86 | $59,572 | $693 |
| Toviaz | 30 | $20,132 | $671 |
| Estradiol | 93 | $16,445 | $177 |
| Premarin | 50 | $15,763 | $315 |
| Solifenacin | 24 | $3,860 | $161 |
| Yuvafem | 25 | $3,623 | $145 |
| Nitrofurantoin Mono-Macro | 110 | $2,400 | $22 |
| Tolterodine Tartrate Er | 19 | $1,758 | $93 |
| Oxybutynin Chloride Er | 17 | $1,595 | $94 |
| Clindamycin Phosphate | 19 | $1,544 | $81 |
| Valacyclovir | 41 | $1,535 | $37 |
| Mometasone Furoate | 62 | $1,034 | $17 |
| Progesterone | 15 | $1,000 | $67 |
| Clobetasol Propionate | 17 | $526 | $31 |
| Trimethoprim | 15 | $416 | $28 |
| Cefuroxime | 11 | $412 | $37 |
| Sulfamethoxazole-Trimethoprim | 28 | $250 | $9 |
| Fluconazole | 36 | $200 | $6 |
| Amoxicillin-Clavulanate Potass | 26 | $173 | $7 |
| Ciprofloxacin | 35 | $158 | $5 |
| Paroxetine | 12 | $103 | $9 |
| Levofloxacin | 12 | $72 | $6 |
2019: 22 drugs
| Myrbetriq | 104 | $67,013 | $644 |
| Vesicare | 37 | $23,468 | $634 |
| Toviaz | 29 | $19,195 | $662 |
| Premarin | 53 | $18,394 | $347 |
| Estradiol | 95 | $18,304 | $193 |
| Yuvafem | 46 | $10,179 | $221 |
| Estrace | 22 | $7,748 | $352 |
| Oxybutynin Chloride Er | 42 | $2,924 | $70 |
| Vagifem | 14 | $2,656 | $190 |
| Nitrofurantoin Mono-Macro | 103 | $2,583 | $25 |
| Mometasone Furoate | 121 | $2,350 | $19 |
| Valacyclovir | 26 | $977 | $38 |
| Clindamycin Phosphate | 11 | $910 | $83 |
| Clobetasol Propionate | 14 | $722 | $52 |
| Sulfamethoxazole-Trimethoprim | 41 | $574 | $14 |
| Cefuroxime | 19 | $489 | $26 |
| Ciprofloxacin | 49 | $434 | $9 |
| Trimethoprim | 11 | $306 | $28 |
| Levofloxacin | 22 | $277 | $13 |
| Amoxicillin-Clavulanate Potass | 25 | $245 | $10 |
| Fluconazole | 28 | $158 | $6 |
| Levothyroxine | 14 | $156 | $11 |
2018: 27 drugs
| Myrbetriq | 105 | $63,827 | $608 |
| Vesicare | 47 | $30,547 | $650 |
| Yuvafem | 59 | $13,999 | $237 |
| Estradiol | 97 | $13,360 | $138 |
| Premarin | 39 | $11,637 | $298 |
| Estrace | 36 | $11,416 | $317 |
| Toviaz | 13 | $9,259 | $712 |
| Vagifem | 21 | $4,389 | $209 |
| Oxybutynin Chloride Er | 63 | $4,178 | $66 |
| Nitrofurantoin Mono-Macro | 90 | $3,651 | $41 |
| Tolterodine Tartrate Er | 14 | $2,351 | $168 |
| Flavoxate | 15 | $1,592 | $106 |
| Mometasone Furoate | 87 | $1,419 | $16 |
| Clobetasol Propionate | 15 | $1,163 | $78 |
| Bethanechol Chloride | 24 | $985 | $41 |
| Progesterone | 15 | $899 | $60 |
| Clindamycin Phosphate | 11 | $887 | $81 |
| Levofloxacin | 40 | $742 | $19 |
| Valacyclovir | 22 | $603 | $27 |
| Imipramine | 17 | $457 | $27 |
| Ciprofloxacin | 50 | $402 | $8 |
| Trimethoprim | 13 | $352 | $27 |
| Sulfamethoxazole-Trimethoprim | 25 | $352 | $14 |
| Amoxicillin-Clavulanate Potass | 27 | $351 | $13 |
| Cefuroxime | 16 | $350 | $22 |
| Fluconazole | 32 | $137 | $4 |
| Pantoprazole | 12 | $77 | $6 |
2017: 24 drugs
| Vesicare | 80 | $54,041 | $676 |
| Myrbetriq | 48 | $31,931 | $665 |
| Estrace | 65 | $18,710 | $288 |
| Vagifem | 41 | $12,291 | $300 |
| Yuvafem | 39 | $12,018 | $308 |
| Premarin | 44 | $11,826 | $269 |
| Toviaz | 14 | $8,740 | $624 |
| Estradiol | 40 | $4,698 | $117 |
| Oxybutynin Chloride Er | 38 | $3,369 | $89 |
| Nitrofurantoin Mono-Macro | 82 | $3,088 | $38 |
| Tolterodine Tartrate Er | 16 | $2,868 | $179 |
| Clobetasol Propionate | 13 | $1,641 | $126 |
| Flavoxate | 12 | $788 | $66 |
| Valacyclovir | 26 | $788 | $30 |
| Mometasone Furoate | 47 | $695 | $15 |
| Ciprofloxacin | 77 | $671 | $9 |
| Bethanechol Chloride | 16 | $553 | $35 |
| Levofloxacin | 29 | $432 | $15 |
| Amoxicillin-Clavulanate Potass | 35 | $396 | $11 |
| Cefuroxime | 12 | $389 | $32 |
| Imipramine | 14 | $201 | $14 |
| Sulfamethoxazole-Trimethoprim | 17 | $186 | $11 |
| Fluconazole | 34 | $151 | $4 |
| Pantoprazole | 12 | $111 | $9 |
2016: 25 drugs
| Vesicare | 124 | $69,841 | $563 |
| Vagifem | 79 | $27,065 | $343 |
| Myrbetriq | 47 | $20,355 | $433 |
| Estrace | 50 | $14,258 | $285 |
| Premarin | 57 | $12,262 | $215 |
| Toviaz | 15 | $8,381 | $559 |
| Nitrofurantoin Mono-Macro | 83 | $3,014 | $36 |
| Clobetasol Propionate | 19 | $2,450 | $129 |
| Oxybutynin Chloride Er | 27 | $2,144 | $79 |
| Tolterodine Tartrate Er | 21 | $2,044 | $97 |
| Estradiol | 30 | $1,904 | $63 |
| Mometasone Furoate | 54 | $1,012 | $19 |
| Flavoxate | 11 | $663 | $60 |
| Clindamycin Phosphate | 11 | $648 | $59 |
| Ciprofloxacin | 83 | $635 | $8 |
| Amoxicillin-Clavulanate Potass | 49 | $540 | $11 |
| Cefuroxime | 16 | $510 | $32 |
| Valacyclovir | 11 | $479 | $44 |
| Sulfamethoxazole-Trimethoprim | 24 | $475 | $20 |
| Bethanechol Chloride | 15 | $444 | $30 |
| Levofloxacin | 32 | $371 | $12 |
| Tamsulosin | 13 | $255 | $20 |
| Fluconazole | 26 | $132 | $5 |
| Cephalexin | 13 | $116 | $9 |
| Pantoprazole | 12 | $113 | $9 |
2015: 24 drugs
| Vesicare | 88 | $39,066 | $444 |
| Vagifem | 109 | $26,959 | $247 |
| Premarin | 94 | $21,961 | $234 |
| Myrbetriq | 43 | $14,691 | $342 |
| Estrace | 50 | $11,870 | $237 |
| Toviaz | 17 | $7,611 | $448 |
| Oxybutynin Chloride Er | 48 | $5,035 | $105 |
| Nitrofurantoin Mono-Macro | 75 | $3,588 | $48 |
| Clobetasol Propionate | 17 | $2,552 | $150 |
| Estradiol | 35 | $2,295 | $66 |
| Mometasone Furoate | 62 | $1,131 | $18 |
| Ciprofloxacin | 117 | $909 | $8 |
| Flavoxate | 13 | $904 | $70 |
| Bethanechol Chloride | 29 | $796 | $27 |
| Tamsulosin | 19 | $624 | $33 |
| Levofloxacin | 48 | $534 | $11 |
| Cefuroxime | 12 | $405 | $34 |
| Fluconazole | 30 | $357 | $12 |
| Alprazolam | 12 | $300 | $25 |
| Sulfamethoxazole-Trimethoprim | 31 | $279 | $9 |
| Amoxicillin-Clavulanate Potass | 30 | $263 | $9 |
| Levothyroxine | 18 | $251 | $14 |
| Pantoprazole | 12 | $135 | $11 |
| Sertraline | 14 | $102 | $7 |
2014: 25 drugs
| Vesicare | 90 | $32,216 | $358 |
| Premarin | 89 | $19,347 | $217 |
| Vagifem | 115 | $18,751 | $163 |
| Estrace | 70 | $11,683 | $167 |
| Toviaz | 32 | $9,177 | $287 |
| Myrbetriq | 19 | $6,662 | $351 |
| Oxybutynin Chloride Er | 57 | $5,290 | $93 |
| Prempro | 28 | $5,055 | $181 |
| Nitrofurantoin Mono-Macro | 75 | $4,415 | $59 |
| Flavoxate | 11 | $1,450 | $132 |
| Mometasone Furoate | 63 | $1,334 | $21 |
| Clobetasol Propionate | 19 | $1,154 | $61 |
| Ciprofloxacin | 135 | $920 | $7 |
| Bethanechol Chloride | 25 | $773 | $31 |
| Nitrofurantoin | 17 | $620 | $36 |
| Estradiol | 28 | $611 | $22 |
| Venlafaxine | 12 | $598 | $50 |
| Cefuroxime | 19 | $550 | $29 |
| Levofloxacin | 32 | $517 | $16 |
| Sulfamethoxazole-Trimethoprim | 59 | $470 | $8 |
| Tamsulosin | 17 | $323 | $19 |
| Amox Tr-Potassium Clavulanate | 24 | $282 | $12 |
| Fluconazole | 28 | $185 | $7 |
| Levothyroxine | 17 | $173 | $10 |
| Pantoprazole | 12 | $160 | $13 |
2013: 27 drugs
| Vesicare | 135 | $36,130 | $268 |
| Vagifem | 136 | $17,258 | $127 |
| Premarin | 87 | $15,403 | $177 |
| Estrace | 68 | $9,889 | $145 |
| Toviaz | 30 | $7,394 | $246 |
| Nitrofurantoin Mono-Macro | 93 | $5,919 | $64 |
| Detrol La | 18 | $5,063 | $281 |
| Oxybutynin Chloride Er | 49 | $4,141 | $85 |
| Prempro | 27 | $3,598 | $133 |
| Enablex | 13 | $2,271 | $175 |
| Vivelle-Dot | 16 | $2,269 | $142 |
| Flavoxate | 12 | $1,868 | $156 |
| Doxycycline Hyclate | 11 | $1,563 | $142 |
| Mometasone Furoate | 56 | $1,449 | $26 |
| Bethanechol Chloride | 21 | $1,407 | $67 |
| Ciprofloxacin | 162 | $921 | $6 |
| Terconazole | 19 | $638 | $34 |
| Tamsulosin | 24 | $602 | $25 |
| Venlafaxine | 11 | $562 | $51 |
| Sulfamethoxazole-Trimethoprim | 59 | $511 | $9 |
| Cefuroxime | 29 | $382 | $13 |
| Estradiol | 25 | $381 | $15 |
| Pantoprazole | 15 | $228 | $15 |
| Amox Tr-Potassium Clavulanate | 14 | $217 | $15 |
| Clobetasol Propionate | 13 | $216 | $17 |
| Fluconazole | 30 | $171 | $6 |
| Levofloxacin | 20 | $147 | $7 |
Money from drug and device companies
$100 in 2023
| 2023 | 1 | 1 | None | $100 |
| 2020 | 1 | 2 | None | $32 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | None | $100 | 1 payment
|
See the published payment
| Astellas Pharma US | Education · 2023-03-30 | None | $100 |
See earlier years (2020)
2020: $32
| Astellas Pharma US | Myrbetriq | $32 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1629179932
- Licence
- CA A41085California A41085: Current · expires 2028-08-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207VG0400X (207VG0400X)
- Mailing address
- 349 S Swall Dr, Beverly Hills, CA, 90211
- NPI first listed
- 2006-09-26
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.